BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8036826)

  • 1. Conversion of orally induced suppression of the mucosal immune response to ovalbumin into stimulation by conjugating ovalbumin to cholera toxin or its B subunit.
    Stok W; van der Heijden PJ; Bianchi AT
    Vaccine; 1994 May; 12(6):521-6. PubMed ID: 8036826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Manipulation of intestinal immune responses against ovalbumin by cholera toxin and its B subunit in mice.
    Van der Heijden PJ; Bianchi AT; Dol M; Pals JW; Stok W; Bokhout BA
    Immunology; 1991 Jan; 72(1):89-93. PubMed ID: 1705237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged oral treatment with low doses of allergen conjugated to cholera toxin B subunit suppresses immunoglobulin E antibody responses in sensitized mice.
    Rask C; Holmgren J; Fredriksson M; Lindblad M; Nordström I; Sun JB; Czerkinsky C
    Clin Exp Allergy; 2000 Jul; 30(7):1024-32. PubMed ID: 10848926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of oral tolerance to ovalbumin by cholera toxin and its B subunit.
    Pierre P; Denis O; Bazin H; Mbongolo Mbella E; Vaerman JP
    Eur J Immunol; 1992 Dec; 22(12):3179-82. PubMed ID: 1446708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cholera toxin adjuvant on IgE antibody response to orally or nasally administered ovalbumin.
    Tamura S; Shoji Y; Hasiguchi K; Aizawa C; Kurata T
    Vaccine; 1994 Oct; 12(13):1238-40. PubMed ID: 7839730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of an enteric Ig-response against ovalbumin and stimulation of the response by cholera toxin and its B-subunit in mice.
    Bianchi AT; Zwart RJ; Van der Heijden PJ
    Reg Immunol; 1990-1991; 3(3):131-8. PubMed ID: 2098068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral tolerance induction with antigen conjugated to cholera toxin B subunit generates both Foxp3+CD25+ and Foxp3-CD25- CD4+ regulatory T cells.
    Sun JB; Raghavan S; Sjöling A; Lundin S; Holmgren J
    J Immunol; 2006 Dec; 177(11):7634-44. PubMed ID: 17114433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral tolerance revisited: prior oral tolerization abrogates cholera toxin-induced mucosal IgA responses.
    Kato H; Fujihashi K; Kato R; Yuki Y; McGhee JR
    J Immunol; 2001 Mar; 166(5):3114-21. PubMed ID: 11207263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of ovalbumin-specific IgA responses via oral boosting with antigen co-administered with an aqueous Solanum torvum extract.
    Israf DA; Lajis NH; Somchit MN; Sulaiman MR
    Life Sci; 2004 Jun; 75(4):397-406. PubMed ID: 15147827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucosal suppression by oral pre-treatment with ovalbumin and its conversion into stimulation when ovalbumin was conjugated to cholera toxin or its B subunit.
    van der Heijden PJ; Stok W; Bianchi AT
    Adv Exp Med Biol; 1995; 371B():1251-5. PubMed ID: 7502794
    [No Abstract]   [Full Text] [Related]  

  • 11. B lymphocytes promote expansion of regulatory T cells in oral tolerance: powerful induction by antigen coupled to cholera toxin B subunit.
    Sun JB; Flach CF; Czerkinsky C; Holmgren J
    J Immunol; 2008 Dec; 181(12):8278-87. PubMed ID: 19050244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of an already established tumor growing through activated mucosal CTLs induced by oral administration of tumor antigen with cholera toxin.
    Wakabayashi A; Nakagawa Y; Shimizu M; Moriya K; Nishiyama Y; Takahashi H
    J Immunol; 2008 Mar; 180(6):4000-10. PubMed ID: 18322209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies for the induction of immune responses at mucosal surfaces making use of cholera toxin B subunit as immunogen, carrier, and adjuvant.
    Holmgren J; Czerkinsky C; Lycke N; Svennerholm AM
    Am J Trop Med Hyg; 1994; 50(5 Suppl):42-54. PubMed ID: 8203723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HMGB1 released from intestinal epithelia damaged by cholera toxin adjuvant contributes to activation of mucosal dendritic cells and induction of intestinal cytotoxic T lymphocytes and IgA.
    Wakabayashi A; Shimizu M; Shinya E; Takahashi H
    Cell Death Dis; 2018 May; 9(6):631. PubMed ID: 29795370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sublingual 'oral tolerance' induction with antigen conjugated to cholera toxin B subunit generates regulatory T cells that induce apoptosis and depletion of effector T cells.
    Sun JB; Czerkinsky C; Holmgren J
    Scand J Immunol; 2007; 66(2-3):278-86. PubMed ID: 17635805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcutaneous immunization with cholera toxin B subunit adjuvant suppresses IgE antibody responses via selective induction of Th1 immune responses.
    Anjuère F; George-Chandy A; Audant F; Rousseau D; Holmgren J; Czerkinsky C
    J Immunol; 2003 Feb; 170(3):1586-92. PubMed ID: 12538724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of natural and recombinant cholera toxin B subunit as stimulatory factors in intranasal immunization.
    de Geus B; Dol-Bosman M; Scholten JW; Stok W; Bianchi A
    Vaccine; 1997 Jul; 15(10):1110-3. PubMed ID: 9269054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppressive versus stimulatory effects of allergen/cholera toxoid (CTB) conjugates depending on the nature of the allergen in a murine model of type I allergy.
    Wiedermann U; Jahn-Schmid B; Lindblad M; Rask C; Holmgren J; Kraft D; Ebner C
    Int Immunol; 1999 Oct; 11(10):1717-24. PubMed ID: 10508191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendritic cell-mediated induction of mucosal cytotoxic responses following intravaginal immunization with the nontoxic B subunit of cholera toxin.
    Luci C; Hervouet C; Rousseau D; Holmgren J; Czerkinsky C; Anjuère F
    J Immunol; 2006 Mar; 176(5):2749-57. PubMed ID: 16493030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholera toxin and its B subunit promote dendritic cell vaccination with different influences on Th1 and Th2 development.
    Eriksson K; Fredriksson M; Nordström I; Holmgren J
    Infect Immun; 2003 Apr; 71(4):1740-7. PubMed ID: 12654787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.